Literature DB >> 16181298

Review article: anorexia and cachexia in gastrointestinal cancer.

J Ockenga1, L Valentini.   

Abstract

In patients with gastrointestinal malignancies, i.e. cancers of the stomach, colon, liver, biliary tract or pancreas, progressive undernutrition can be regularly observed during the course of illness. Undernutrition significantly affects the patients' quality of life, morbidity and survival. Pathogenetically, two different causes are relevant in the development of undernutrition in patients with gastrointestinal cancer. One cause is reduced nutritional intake. This condition is referred to as anorexia and can be worsened by the side effects of cancer therapy. The other cause is the release of endogenous transmitters and/or other products of the tumour leading to the cachexia syndrome, which is characterized by loss of body weight, negative nitrogen balance and fatigue. Cancer anorexia and cancer cachexia may have synergistic negative effects in affecting the patients' status. In this review, current nutritional support strategies with respect to different clinically relevant situations are described. An algorithm of the treatment strategies, including dietetic counselling, oral supplements, enteral and parenteral nutritional support is given. One focus is the approach of nutrition-focused patient care, which shows promising results. In addition, the possibilities of pharmacological intervention are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16181298     DOI: 10.1111/j.1365-2036.2005.02628.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

Review 1.  Targeting aldose reductase for the treatment of cancer.

Authors:  Ravinder Tammali; Satish K Srivastava; Kota V Ramana
Journal:  Curr Cancer Drug Targets       Date:  2011-06       Impact factor: 3.428

2.  Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis.

Authors:  Peter D Peng; Mark G van Vledder; Susan Tsai; Mechteld C de Jong; Martin Makary; Julie Ng; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Michael A Choti; Ihab Kamel; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

Review 3.  What to eat when off treatment and living with involuntary weight loss and cancer: a systematic search and narrative review.

Authors:  Jane B Hopkinson; Ikumi Okamoto; Julia M Addington-Hall
Journal:  Support Care Cancer       Date:  2010-08-06       Impact factor: 3.603

4.  Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma.

Authors:  Peter Peng; Omar Hyder; Amin Firoozmand; Peter Kneuertz; Richard D Schulick; Donghang Huang; Martin Makary; Kenzo Hirose; Barish Edil; Michael A Choti; Joseph Herman; John L Cameron; Christopher L Wolfgang; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2012-06-13       Impact factor: 3.452

5.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

6.  Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study.

Authors:  Uwe Pelzer; Dirk Arnold; Mehmet Gövercin; Jens Stieler; Bernd Doerken; Hanno Riess; Helmut Oettle
Journal:  BMC Cancer       Date:  2010-03-09       Impact factor: 4.430

Review 7.  Nutritional status and nutritional support before and after pancreatectomy for pancreatic cancer and chronic pancreatitis.

Authors:  Vasiliki Th Karagianni; Apostolos E Papalois; John K Triantafillidis
Journal:  Indian J Surg Oncol       Date:  2012-10-30

Review 8.  Role of supportive care for terminal stage hepatocellular carcinoma.

Authors:  Manoj Kumar; Dipanjan Panda
Journal:  J Clin Exp Hepatol       Date:  2014-03-31

Review 9.  Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison.

Authors:  Tamhida Masi; Bhoomika M Patel
Journal:  Pharmacol Rep       Date:  2020-11-03       Impact factor: 3.024

10.  Microencapsulated Bifidobacterium bifidum and Lactobacillus gasseri in Combination with Quercetin Inhibit Colorectal Cancer Development in ApcMin/+ Mice.

Authors:  Iván Benito; Ignacio J Encío; Fermín I Milagro; María Alfaro; Ana Martínez-Peñuela; Miguel Barajas; Florencio Marzo
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.